Tokyo University Researcher Identifies Proteins Necessary For Flu Virus Replication
This article was originally published in PharmAsia News
A Tokyo University research team identified three proteins that are necessary for flu virus replication. By analyzing the genome of drosophila, as it has more similarities with human DNA, the team identified three implicated drosophila genes. The corresponding human homologues are shown to have key functions in the replication of H5N1 and H1N1 influenza A viruses. According to the team, the discovery of the host proteins that are required for influenza virus replication could accelerate the development of new classes of antiviral drugs for chemoprophylaxis and treatment. The results were published July 10 in the British journal Nature. (Click here for more - Japanese language
You may also be interested in...
Results from two trials confirm patients at high risk of bleeding treated with Abbott’s Xience stent can be safely treated with short regimens of dual antiplatelet therapy.
Through a licensing-out deal with ORIC for its EGFR/HER2 exon-20 inhibitor, South Korea's Voronoi hopes to gain from its new partner's commercialization experience in NSCLC. The alliance hopes to build a potentially best-in-class presence in a competitive landscape.
An expert panel at the virtual HLTH conference discussed the role of robotics in improving health and wellness in the health continuum. See what Darla Hutton, vice president of US marketing and customer hospital analytics at Intuitive Surgical, said about the future of robotics.